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Abstract
Protein arginine methylation is a common posttranslational modification that
has been implicated in numerous biological processes including gene
expression. The mammalian genome encodes nine protein arginine
methyltransferases (Prmts) that catalyze monomethylation, asymmetric
dimethylation, and symmetric dimethylation on arginine residues. Protein
arginine methyltransferase 7 (Prmt7) is categorized as a type II and type III
enzyme that produces symmetric dimethylated arginine and monomethylated
arginine, respectively. However, the biological role of Prmt7 is not well
characterized. We previously showed that Prmt5, a type II Prmt that associates
with Brg1-based SWI/SNF chromatin remodeling complex, is required for
adipocyte differentiation. Since Prmt7 also associates with Brg1-based
SWI/SNF complex and modifies core histones, we hypothesized that Prmt7
might play a role in transcriptional regulation of adipogenesis. In the present
study, we determined that the expression of Prmt7 did not change throughout
adipogenic differentiation of C3H10T1/2 mesenchymal cells. Knockdown or
over-expression of Prmt7 had no effect on lipid accumulation or adipogenic
gene expression in differentiating C3H10T1/2 cells or in
C/EBPα-reprogrammed NIH3T3 fibroblasts. Based on these results, we
conclude that Prmt7, unlike Prmt5, is dispensable for adipogenic differentiation
in tissue culture models.
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in differentiating cells. Based on the results, we concluded that 
Prmt7 is not required for differentiation in tissue culture models of 
adipogenesis.
Methods
Cell culture
Mouse C3H10T1/2 and NIH3T3 cells were obtained from the 
ATCC. C3H10T1/2 cells were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) high glucose (Invitrogen) supplemented 
with 10% fetal calf serum (FCS) (Sigma) and 100U/ml of penicillin/
streptomycin (Invitrogen). NIH3T3 cells were maintained in DMEM 
high glucose with 10% calf serum (Sigma). 293T and BOSC23 cells 
were obtained from S.N. Jones (UMass Medical School) and R.E. 
Kingston (Massachusetts General Hospital), respectively, and were 
grown in the same medium as C3H10T1/2 cells. For adipogenic 
differentiation, two-day postconfluent cells were differentiated with 
DMEM medium containing 10% FCS, 10μg/ml insulin, 0.5mM 
3-isobutyl-1-methyxanthine, 1μM dexamethasone, and 10μM tro-
glitazone (Sigma). After 48 hours incubation, media on the differ-
entiating cells was replaced with media containing 5μg/ml insulin. 
Subsequently, the media was changed every other day until harvest. 
To evaluate cell proliferation, 1×105 cells were seeded in 6-well 
plates (Corning Inc.), and the number of viable cells was counted 
under a microscope (CK2, Olympus) each day from day 1 to day 4 
with a hemocytometer (Hausser Scientific).
Plasmid DNA constructs
pENTR/pTER+ vector and pLentiX2 Dest vector were gifts from 
Dr. Eric Campeau (UMass Medical School). The preparation of len-
tiviral small hairpin RNA (shRNA) constructs was done as previ-
ously described12,23. Briefly, shPrmt7-1, shPrmt7-2 and scrambled 
control oligonucleotides were cloned into a pENTR/pTER+ vector. 
These constructs were individually incubated with the pLentiX2 
DEST vector and LR clonase II enzyme mix (Invitrogen) to gener-
ate pLentiX2 DEST/ shPrmt7-1, pLentiX2 DEST/shPrmt7-2 and 
pLentiX2 DEST/shCtrl constructs. These lentiviral constructs were 
amplified in Stbl3 competent cells (Invitrogen) for generating len-
tiviruses. The pBABE puromycin empty vector (pBABE vector), 
FLAG-tagged PRMT7 construct (pBABE PRMT7) and pBABE 
CEBPα construct were previously described12,24 and were individu-
ally amplified in TOP10 competent cells (Invitrogen) for generating 
retroviral DNA as previously described12,24.
Virus production and infection
The preparation of viruses was performed as previously described23,25. 
Briefly, for lentiviruses, the packaging vectors pLP1, pLP2, pVSVG 
(Invitrogen) and pLentiX2 DEST/shRNA constructs were co-trans-
fected into 293T cells with Lipofectamine 2000 reagent (Invitrogen) 
according to the manufacturer’s instructions. BOSC23 cells were 
used for pBABE-based retrovirus production. After 48 hours incu-
bation, the supernatant was harvested and filtered through 0.45μm 
syringe filter (Millipore). For viral infection, 1ml of the filtered 
supernatant and 4μg/ml of polybrene (Sigma) were used to infect 
one million cells. After 48 hours incubation, virus infected cells 
were selected in 2.5μg/ml puromycin (Invitrogen).
Protein expression analysis
Cells were washed twice with cold PBS and were harvested in 
RIPA buffer (50mM Tris-HCl pH7.4, 150mM NaCl, 1mM EDTA, 
Introduction
Research over the past 15 years has demonstrated the importance of 
protein arginine methylation in various biological processes includ-
ing transcriptional regulation, DNA repair, RNA processing, and 
signal transduction1–5. The fact that hundreds of cellular proteins 
have been identified as the targets of protein arginine methylation 
supports the idea that arginine methylation regulates diverse cel-
lular processes6. Arginine methylation is catalyzed by protein argi-
nine methyltransferases (Prmts) that transfer a methyl group from 
S-adenosyl methionine (AdeMet) to protein substrates. To date, 
nine protein arginine methyltransferases have been identified in the 
mammalian genome and have been classified as type I, type II and 
type III enzymes by the activity of producing ω-NG,NG-asymmetric 
dimethylarginine (ADMA), ω-NG,NG-symmetric dimethylarginine 
(SDMA), and ω-NG-monomethylarginine (MMA), respectively2,4,7.
Among the family of Prmts, Prmt7 is unique in that it possesses 
two AdoMet-binding domains, which may have resulted from a 
gene duplication event8. As for many of the Prmts, histones are 
among the identified substrate molecules, suggesting a functional 
role for Prmt7 in regulating gene expression as a chromatin modi-
fier. Initial work indicated that H2A and H4 were symmetrically 
dimethylated by Prmt7 in vitro9, whereas several studies have 
reported that Prmt7 only produces MMA on histones and other 
substrates8,10,11. A recent study indicated that Prmt7 symmetrically 
dimethylates H4R3 and H2AR3 in a manner that contributes to the 
repression of expression of genes involved in DNA repair12. Another 
study revealed that Prmt7-mediated H4R3 symmetric dimethylation 
antagonizes MLL4-catalyzed H3K4 methylation on neuron-specific 
gene promoters during differentiation13, suggesting that Prmt7 might 
negatively regulate tissue differentiation by its chromatin-modifying 
activity. Aside from the role in neuronal differentiation, the regula-
tory function of Prmt7 in the differentiation of other lineages has 
not been reported.
Adipocyte differentiation is one of the most intensively studied dif-
ferentiation processes. Both human and mouse mesenchymal stem 
cells (MSCs) that reside in fat pads and bone marrow undergo line-
age commitment and terminal differentiation to become mature adi-
pocytes14–16. The adipogenic differentiation process is controlled by a 
number of tissue-specific transcription factors, such as the CCAAT/
enhancer binding proteins (C/EBPs), peroxisome proliferator- 
activated receptor gamma (PPARγ), and numerous chromatin 
remodeling and modifying enzymes including the ATP-dependent 
SWI/SNF complex and Prmts17–20. It has been shown that Prmt5 
interacts with Brg1-based SWI/SNF complex21 and facilitates the 
binding of Brg1 to the PPARγ and to PPARγ target promoters to 
facilitate the activation of adipogenic genes19. Furthermore, Prmt4, 
which also has been shown to interact with Brg1-based SWI/SNF 
complex22, acts as a co-activator of PPARγ to promote adipocyte 
gene expression20. Prmt7 had been recently shown to interact with 
Brg1-based SWI/SNF complex12, but whether Prmt7 has functional 
roles in adipocyte differentiation remains unclear.
In the present study, we examined the role of Prmt7 in adipocyte 
differentiation in mouse C3H10T1/2 embryonic mesenchymal cells 
and in C/EBPα-reprogrammed murine NIH3T3 fibroblasts. By 
knocking down and over-expressing Prmt7, we showed that Prmt7 
has no effect on lipid accumulation and adipogenic gene expression 
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1% Nonidet P-40 (Thermo Scientific) and 0.25% sodium deoxy-
cholate) supplemented with protease inhibitor cocktail (Roche). 
The samples were sonicated at high intensity setting for 3 minutes 
with 30sec on/off cycle in a Bioruptor (UCD-200, Diagenode). 
After quantifying the protein concentration by means of a Bio-Rad 
protein assay, the protein samples were then mixed with 4× SDS 
loading buffer (240mM Tris-HCl pH6.8, 8% SDS, 40% glycerol, 
0.01% bromophenol blue and 10% β-mercaptoethanol) and boiled at 
95°C for 10min. 30μg protein samples were separated on 10% SDS-
PAGE and transferred onto PVDF membrane (Bio-Rad). The blots 
were blocked overnight in 3% non-fat milk (Essential Everyday). The 
next day, proteins were detected using specific antibodies (1:1000 
dilution) and HRP-conjugated secondary antibodies (1:2000 
dilution). The rabbit polyclonal antibodies against human PRMT7 
(sc-98882) and rat C/EBPα (sc-61) were purchased from Santa 
Cruz Biotechnology. The mouse monoclonal antibody against 
mouse PPARγ (sc-7273) and the goat polyclonal antibody against 
human PRMT5 (sc-22132) were also purchased from Santa Cruz 
Biotechnology. Rabbit polyclonal anti-PI3K (ABS233) antibody 
was from Millipore. The secondary antibodies (NA9340 and 
NA9310) were purchased from GE Healthcare Life Sciences. The 
blots were developed on X-ray films with ECL Western Blotting 
Detection Reagents (GE Healthcare Life Sciences). The signal in-
tensity was quantified by ImageJ.
Gene expression analysis
Total RNA was isolated from samples using TRIzol reagent (Inv-
itrogen) according to the manufacturer’s instructions. cDNA was 
prepared from 1μg of total RNA by Superscript III reverse tran-
scriptase kit (Invitrogen). Quantitative PCR was performed on 
StepOne Plus real-time PCR machine with Fast SYBR Green Mas-
ter mix (Applied Biosystems). The specific primers for gene expres-
sion analysis were:
Fasn forward 5′-CGTGTTGGCCTACACCCAGAGCT-3′;
Fasn reverse 5′-GGCAGCAGGGCCTCCAGCACCTT-3′;
AdipoQ forward 5′-CAGTGGATCTGACGACACCA-3′;
AdipoQ reverse 5′-CGAATGGGTACATTGGGAAC-3′;
Fabp4 forward 5′-GCGTGGAATTCGATGAAATCA-3′;
Fabp4 reverse 5′-CCCGCCATCTAGGGTTATGA-3′;
5S rRNA forward 5′-GTCTACGGACATACCACCCTG-3′;
5S rRNA reverse 5′-TACAGCACCCGGTATTCCCAG-3′.
Relative expression levels were determined by the comparative Ct 
method26.
Oil Red O staining
Differentiating cells were washed once with PBS and fixed in 10% 
phosphate-buffered formalin (Fisher Scientific) overnight. The next 
day, the fixed cells were washed with 60% isopropanol and air-
dried completely. The cells were then stained with 60% Oil Red O 
(AMRESCO) for 10 minutes and washed repeatedly with tap water 
to remove excess stain. To quantify staining, Oil Red O was extract-
ed from the cells with 100% isopropanol, and the optical density 
was measured at 500nm (OD500).
Results
The protein levels of Prmt7 remain constant during adipogenic 
differentiation of C3H10T1/2 cells
The C3H10T1/2 cell line was established from C3H mouse embryos 
and has served as a faithful cell culture model for mesenchymal lin-
eage differentiation27–29. C3H10T1/2 cells can be differentiated into 
mature adipocytes by treating the confluent cells with a cocktail 
that contains insulin, dexamethasone, 3-isobutyl-1-methyxanthine 
(IBMX) and PPARγ ligands30. Using this model, we first examined 
Prmt7 protein levels during adipogenic differentiation by Western 
blot analysis. We found that Prmt7 protein levels are relatively con-
stant from the onset of differentiation (day 0) through the day 6 
post-differentiation (Figure 1A and Figure 1B) (Dataset 1). We con-
cluded that Prmt7 protein levels were not altered in differentiating 
C3H10T1/2 cells.
Virus-mediated knockdown and over-expression of Prmt7 
in C3H10T1/2 cells
To study the function of Prmt7, we used viral vectors to knock down 
or over-express Prmt7 in C3H10T1/2 cells. Two lentiviral constructs 
(pLentiX2 DEST/shPrmt7-1 and pLentiX2 DEST/shPrmt7-2) that 
encode shRNAs against Prmt7 mRNA were used for knocking down 
endogenous Prmt7 in proliferating C3H10T1/2 cells. A pBABE 
retroviral construct (pBABE-PRMT7) encoding FLAG-tagged 
PRMT7 was used to over-express PRMT7. The virus-infected cells 
were selected with puromycin and the levels of Prmt7 in the selected 
cells were examined by Western blot analysis (Figure 2A). Endog-
enous Prmt7 levels were reduced 10-fold or more in the knockdown 
Figure 1. Prmt7 protein levels are constant in differentiating 
C3H10T1/2 cells. (A) Western blot analysis of the protein extracts from 
day 0 to day 6 post-differentiated C3H10T1/2 cells. Duplicate blots 
were probed with anti-Prmt7 antibody and with anti-PI3K antibody as 
a loading control. (B) The quantification of (A) by ImageJ. The levels 
of Prmt7 were normalized to PI3K loading control and presented as 
the relative expression levels to the day 0 sample (day 0=1). The 
data represent the average of two independent experiments (n=2).
Prmt7 
PI3K  
    0      1      2       3      4      5      6      (day)  
B 
A 
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Figure 2. Prmt7 was specifically knocked down or over-expressed in C3H10T1/2 cells. (A) A representative Western blot analysis from 
proliferating C3H10T1/2 cells with Prmt7 knockdown and over-expression. Endogenous Prmt7 was specifically depleted by two different 
lentiviral shRNA constructs (shPrmt7-1 and shPrmt7-2). The scrambled shRNA lentiviral construct (shCtrl) was used as a control. The pBABE 
retroviral construct encoding FLAG-tagged PRMT7 (pBABE - PRMT7;12) was used to ectopically express PRMT7, and the pBABE empty 
vector (pBABE vector) was used as a control. Duplicate blots were probed with anti-Prmt7 and anti-Prmt5 antibodies and with anti-PI3K 
antibody as a loading control. (B) The quantification of Prmt7 in (A) by ImageJ. The levels of Prmt7 were normalized to the PI3K loading 
control and are presented as expression levels relative to the scrambled shRNA control or pBABE empty vector control. The data represent 
the average of two independent experiments (n=2).
cells compared to the scrambled shRNA control cells (Figure 2B). 
Prmt7 levels were increased more than 5-fold in the FLAG-tagged 
PRMT7 over-expression cells compared to the pBABE empty vec-
tor control (Figure 2B) (Dataset 2). Since Prmt5 is the major type 
II arginine methyltransferase and is also associated with SWI/SNF 
complexes21, we examined Prmt5 protein levels in our samples. We 
observed no changes in Prmt5 levels in Prmt7 knockdown and over-
expression C3H10T1/2 cells (Figure 2A).
Prmt7 has no effect on cell proliferation of C3H10T1/2 cells
Both Prmt7 and Prmt5 exhibit type II arginine methyltransferase 
activity. However, unlike Prmt5, Prmt7 has no effect on cell prolif-
eration in NIH3T3 fibroblasts12. We measured the cell proliferation 
rate of Prmt7 knockdown and over-expression C3H10T1/2 cells, and 
found that neither the reduction of Prmt7 nor the over-expression 
of Prmt7 affected the proliferation of C3H10T1/2 cells (Figure 3) 
(Dataset 3). This result is consistent with the results from the previ-
ous study on NIH3T3 fibroblasts12.
Prmt7 is not required for adipogenic differentiation of 
C3H10T1/2 cells
To determine whether Prmt7 affects adipogenesis, the Prmt7 knockdown 
and over-expression C3H10T1/2 cells were grown to confluence and 
treated with the differentiation cocktail. At day 6 post-differentiation, 
the accumulation of intracellular neutral lipids was measured by 
Figure 3. Knockdown or over-expression of Prmt7 does not affect 
C3H10T1/2 cell proliferation. The growth rates of control (shCtrl 
and pBABE vector), Prmt7 knockdown (shPrmt7-1 and shPrmt7-2) 
and Prmt7 over-expression (pBABE PRMT7) C3H10T1/2 cells 
were measured by seeding 1×105 cells in 6-well plates, and the 
viable cells were counted each day for 4 days after seeding. 
The data represent the average of two independent experiments 
(n=2) counted in duplicate. Error bars show the standard 
deviation.
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Figure 4. Knockdown or over-expression of Prmt7 has no effect on C3H10T1/2 adipogenic differentiation. (A) Representative Oil-Red 
O staining images of day 6 post-differentiated C3H10T1/2 cells in which Prmt7 was either knocked down (shPrmt7-1 and shPrmt7-2) or over-
expressed (pBABE PRMT7). The Prmt7 knockdown and over-expression C3H10T1/2 cells were grown to confluence and differentiated 48 h 
later. At day 6 post-differentiation, the cells were fixed with 10% formalin and stained with Oil-Red O. (B) The quantification of (A). The Oil-Red 
O stain was extracted with 100% isopropanol and the optical density at 500nm (OD500) was determined. The data represent the average of 
two independent experiments (n=2) assayed in duplicate. Error bars show standard deviation. (C) A representative Western blot analysis 
of endogenous Prmt7, PPARγ and C/EBPα expression in day 6 post-differentiated C3H10T1/2 cells. The levels of PI3K are presented as a 
loading control. (D) Gene expression analysis on day 6 post-differentiated C3H10T1/2 cells. The mRNA levels of fatty acid synthase (Fasn), 
adiponectin (AdipoQ) and fatty acid binding protein 4 (Fabp4) were measured by RT-qPCR. The individual mRNA levels were normalized to 
5S rRNA. The normalized expression levels of the control cells in one of the experiments were set as 1. The data are presented as the average 
of relative expression levels from two independent experiments (n=2) assayed in duplicate. Error bars show standard deviation.
Oil Red O staining. The Oil Red O staining showed similar levels 
of lipid accumulation in Prmt7 knockdown as well as Prmt7 over-
expression cells as compared to the control cells. (Figure 4A and 
Figure 4B) (Dataset 4). This result suggests that the changes in 
Prmt7 levels did not affect lipid accumulation in differentiating 
C3H10T1/2 cells.
Adipogenic gene and protein expression in C3H10T1/2 cells 
was not affected by Prmt7 knockdown or over-expression
PPARγ and C/EBPα are the key transcription factors for adipo-
genic differentiation and for the maintenance of the adipocyte 
phenotype31–34. We examined the protein levels of PPARγ and 
C/EBPα in day 6 post-differentiation cells by Western blot analy-
sis and found no significant difference in either Prmt7 knockdown 
or Prmt7 over-expression cells compared to the corresponding con-
trols (Figure 4C). In addition, to rule out the possibility that Prmt7 
functions as a cofactor of PPARγ and C/EBPα, we measured the 
mRNA expression levels of PPARγ and C/EBPα target genes in day 6 
post-differentiation samples by real-time quantitative PCR (Figure 4D) 
(Dataset 5). We found that Prmt7 had no significant impact on fatty 
acid synthase (Fasn), adiponectin (AdipoQ), and fatty acid bind-
ing protein 4 (Fabp4) gene expression in the differentiating cells. 
These results suggest that Prmt7 is dispensable for adipogenic gene 
expression.
Prmt7 has no effect on C/EBPα-reprogrammed NIH3T3 
fibroblasts
Previous studies had shown that ectopic expression of PPARγ or 
C/EBPα alone in non-adipogenic NIH3T3 cell line is able to repro-
gram NIH3T3 fibroblasts into adipocyte-like cells33,34. To test if Prmt7 
is required for the reprogramming of NIH3T3 fibroblasts, we first 
knocked down and over-expressed Prmt7 in NIH3T3 fibroblasts by 
using the same viral constructs that we used in C3H10T1/2 cells, 
and confirmed the knockdown and over-expression of Prmt7 by 
Western blot analysis (Figure 5A). These cells were further infected 
with retroviruses encoding C/EBPα at 70% confluence. After the 
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Discussion
Changes in gene expression during cell differentiation require alter-
ations in higher-order chromatin organization as well as in local 
chromatin structure. Cells possess histone modifying enzymes 
and ATP-dependent chromatin remodeling enzymes to facilitate 
chromatin changes. The interplay between these two families of 
enzymes has been shown to be crucial for both transcription activa-
tion and repression18,21,35. Prmt7 was identified as a histone arginine 
methylating enzyme9–11 and was shown to associate with Brg1-based 
SWI/SNF ATP-dependent chromatin remodeling complex12. These 
findings led us to investigate the possible roles of Prmt7 in adipo-
genic differentiation, which is a process that requires the function 
of Brg1-based SWI/SNF complex24. Our data clearly showed that 
Prmt7 levels were significantly changed in the knockdown or over-
expression cells, but manipulation of Prmt7 levels did not cause 
a differentiation deficiency. It is established that Brg1-based SWI/
SNF complex is recruited to the adipogenic promoters upon dif-
ferentiation24. However, whether Prmt7 associates with Brg1-based 
SWI/SNF complex at adipogenic promoters is still unknown. Since 
Prmt7 has no effect on adipogenic gene expression, we expect that 
Prmt7 is not recruited to adipogenic promoters. Alternatively, even 
if there is binding, the function of Prmt7 is dispensable at these loci.
Functional redundancy within the Prmt family has not been char-
acterized. Prmt7 was classified as a type II and a type III arginine 
methyltransferase by characterization of its in vitro catalytic activ-
ity8–11. Whether other Prmts functionally compensate for Prmt7 is 
still unknown. The predominant type II arginine methyltransferase 
Prmt5 catalyzes the formation of MMA and SDMA in a nonpro-
cessive fashion36,37. Type I arginine methyltransferases also produce 
MMA38–40. It is possible that Prmt5 or type I Prmts partially or fully 
compensate for the loss of Prmt7 in the cells. Our data showed 
that Prmt7 knockdown or over-expression has no effect on Prmt5 
protein levels in C3H10T1/2 cells. This observation is consistent 
with the results from the previous study in HeLa cells41. However, 
we still cannot rule out the possibility that Prmt5 compensates for 
Prmt7 enzyme activity, even though Prmt5 protein levels remain 
constant. Further investigation is needed to address the possible 
crosstalk between Prmt5 and Prmt7 in chromatin regulation.
To our knowledge, Prmt7 knock-out or transgenic mice have not 
been reported. Whether changes in Prmt7 levels cause any develop-
mental deficiencies in vivo remains unknown. However, several stud-
ies using cell lines or tissues have revealed regulatory roles for Prmt7 
in tissue-specific gene expression. For example, PRMT7 negatively 
regulates neuronal differentiation of a human embryonal carcinoma 
cell line by repressing the expression of differentiation-specific 
genes13. In mouse germ cells, Prmt7 was recruited to the imprinting 
control region through physical interaction with CTCFL, a testis-
specific nuclear protein, and repressed imprinted gene expression42. 
Furthermore, mouse embryonic stem cells and germ cells have rela-
tive high levels of Prmt7 compared with mouse embryonic fibro-
blasts43,44. This evidence suggests that Prmt7 might have important 
functions in the maintenance of stem cell pluripotency and that 
the down-regulation of Prmt7 might be required for early cell fate 
Figure 5. Knockdown or over-expression of Prmt7 has no effect 
on C/EBPα-mediated reprogramming of NIH3T3 fibroblasts. (A) 
Western blot analysis on Prmt7 knockdown and over-expression 
NIH3T3 fibroblasts. Endogenous Prmt7 was specifically depleted 
by the lentiviral shRNA constructs (shPrmt7-1 and shPrmt7-2). 
The scrambled shRNA lentiviral construct (shCtrl) was used as a 
control. The pBABE retroviral construct encoding FLAG-tagged 
PRMT7 (pBABE PRMT7) was used to ectopically express PRMT7 
and the pBABE empty vector was used as a control. The blot was 
probed with anti-Prmt7 antibody, and the PI3K levels are presented 
as a loading control. (B) Oil-Red O staining images of C/EBPα-
reprogrammed NIH3T3 fibroblasts at day 6 post-differentiation. 
Prmt7 knockdown and over-expression NIH3T3 fibroblasts were 
infected with retroviruses encoding C/EBPα at 70% confluence. 
Two day post-confluent cells were differentiated. At day 6 post-
differentiation, the cells were fixed with 10% formalin and stained 
with Oil-Red O.
cells reached confluence, the differentiation cocktail was added to 
stimulate adipogenic differentiation. At day 6 post-differentiation, 
the accumulated lipid was evaluated by Oil Red O staining 
(Figure 5B). We found that neither knockdown nor over-expression 
of Prmt7 caused a significant difference in Oil Red O staining in 
C/EBPα-reprogrammed NIH3T3 fibroblasts, which is consistent 
with the results in C3H10T1/2 cells.
Data files Prmt7 and adipocyte differentiation
5 Data Files
http://dx.doi.org/10.6084/m9.figshare.877037
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